The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome.
about
Resistance to rituximab therapy and local BAFF overexpression in Sjögren's syndrome-related myoepithelial sialadenitis and low-grade parotid B-cell lymphomaRituximab Effectiveness and Safety for Treating Primary Sjögren's Syndrome (pSS): Systematic Review and Meta-AnalysisExploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndromeKey issues in the management of patients with systemic lupus erythematosus: latest developments and clinical implicationsSex differences in Sjögren's syndrome: a comprehensive review of immune mechanismsB-cell survival factors in autoimmune rheumatic disordersRole of type I interferons in the activation of autoreactive B cellsFactors regulating immunoglobulin production by normal and disease-associated plasma cellsMultiple Roles for B-Lymphocytes in Sjogren's SyndromeElevated B cell-activating factor of the tumour necrosis factor family in coeliac diseaseA soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeysReviewing primary Sjögren's syndrome: beyond the dryness - From pathophysiology to diagnosis and treatmentTreatment of primary Sjögren syndrome.Antibodies as therapeutic agents: vive la renaissance!High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura.BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism.Sjogren's syndrome: Review of the aetiology, Pathophysiology & Potential therapeutic interventions.Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.The strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF).Unraveling the pathophysiology of Sjogren syndrome-associated dry eye diseaseBAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitisHigh levels of B-cell activating factor in patients with active chronic graft-versus-host disease.B cells and transplantation: an educational resource.Belimumab for the treatment of systemic lupus erythematosus.Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond.Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignanciesAltered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndromeB cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndromeCurrent and emerging treatment options for ANCA-associated vasculitis: potential role of belimumab and other BAFF/APRIL targeting agents.B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls.Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and diseaseUse of localised gene transfer to develop new treatment strategies for the salivary component of Sjögren's syndrome.Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.Primary Sjögren's syndrome: new clinical and therapeutic conceptsRaised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis.Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome.Aspects of innate immunity in Sjögren's syndrome.
P2860
Q24644580-8890DB3D-23A7-4B17-9BA0-6916C07BC7CBQ26753072-7421346E-A34B-4ACA-AC55-CC68F3B025FDQ26770648-CD654F44-D22F-4098-B2E6-6C43119B2701Q26775756-40D60240-37C0-43AC-9A79-FE5EB1BEB250Q26780324-110934E3-A795-49B2-A062-346C5D12B0D5Q26796484-9FDFDB9F-033D-451C-8920-DC91563D86F8Q26858821-4C465CA0-ABB5-4033-82AB-686241D9362CQ27021855-EA205AA5-3DC3-4B9E-A0FD-2C77B7048777Q28068695-B9D0888A-A53A-4E00-B98A-F22156CE4928Q28248398-A95ACC0C-6531-4EDC-A1F4-F8EC5B086592Q28293722-208EE09F-84C7-4721-B8DD-4376217F59CAQ30234992-E44FD5AB-AE58-446D-95BF-289B1AFD57C6Q30249011-764D595C-FB7D-42C5-8483-136E74F16251Q33193524-D8174B01-2408-44DE-985F-B0BC4F2C716AQ33373525-0E137909-31A5-4D42-ABAE-AA20353F3FEFQ33381985-9AB7F6A8-8344-40E6-9894-1495EBD144B3Q33584291-5F01941D-2608-4871-AF16-D17A155DA458Q33619691-DD4CDA49-6BBE-45D9-BD4A-76386A36A008Q33758184-1892FE93-B4E7-4667-8207-4598719665A1Q33792424-335679CB-7B84-497B-B20D-F2CAA3A25BCEQ33819490-DC9EB423-7E07-41E4-BAF9-EA835B5EF2C1Q34012753-A356C5AB-070E-4FCC-845E-DA941DF664F8Q34135089-43E4C788-7C7B-43BE-8568-02E461582E60Q34152189-EBD1AC60-229C-4084-9F54-9C84F69A8F23Q34455827-45C67699-7432-47DE-A357-E09C2ECBE015Q34495557-24BAD260-9D77-4D7D-A4B6-D0EFDE5A021AQ34619806-22EC186D-5767-416B-8E55-D6C2CEE1BB21Q34669630-2F432E44-3F86-495F-B53D-84294008752FQ34743817-486A2970-6FA5-4802-A854-02DB73EACA04Q34896464-469837D2-09DE-4A29-A34A-E2741B8B396BQ34896699-A489DA79-DD7E-4675-8931-A130249DBD46Q34960458-A13C1DAE-03A5-4951-94F9-E906D2E552C7Q35067840-612F255B-4FDC-4F8D-99F1-09C673D8B631Q35452032-D7AA61F3-D2A4-42E5-8E68-E0E8461D1B59Q35552189-38FB7953-DAE3-48AB-95C4-ADF2E7DA4154Q35554665-0EAEAC09-1185-4F9A-9034-85A04F0D887EQ35555323-C560121F-8ECC-4A82-BB6E-0675808429BDQ35555539-7302AB0D-36E0-48C0-B40E-3C5569A5314AQ35555698-23D6F575-5C86-4BF1-BA70-4672745F458AQ35557792-6BDD01F2-608D-4664-AEA6-65DAE111CC62
P2860
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The level of BLyS (BAFF) corre ...... s in human Sjögren's syndrome.
@en
The level of BLyS
@nl
type
label
The level of BLyS (BAFF) corre ...... s in human Sjögren's syndrome.
@en
The level of BLyS
@nl
prefLabel
The level of BLyS (BAFF) corre ...... s in human Sjögren's syndrome.
@en
The level of BLyS
@nl
P2093
P2860
P356
P1476
The level of BLyS (BAFF) corre ...... s in human Sjögren's syndrome.
@en
P2093
P2860
P304
P356
10.1136/ARD.62.2.168
P407
P577
2003-02-01T00:00:00Z